scholarly article | Q13442814 |
P356 | DOI | 10.1093/JB/MVN074 |
P698 | PubMed publication ID | 18515856 |
P2093 | author name string | Xiaofeng Huang | |
Han-Mei Xu | |||
Zilong Shen | |||
Naseruddin Höti | |||
Siraj Sami | |||
P2860 | cites work | Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo | Q40253999 |
Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor | Q40392211 | ||
Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells | Q40506047 | ||
Triphenyl tin benzimidazolethiol, a novel antitumor agent, induces mitochondrial-mediated apoptosis in human cervical cancer cells via suppression of HPV-18 encoded E6. | Q40618206 | ||
Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2–M transition | Q40629817 | ||
Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression | Q42657689 | ||
Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells | Q44257942 | ||
Valproic acid inhibits angiogenesis in vitro and in vivo | Q44772882 | ||
Effects of chronic administration of olanzapine, amitriptyline, haloperidol or sodium valproate in naive and anhedonic rats | Q46556776 | ||
Valproic acid induces extracellular signal-regulated kinase 1/2 activation and inhibits apoptosis in endothelial cells | Q46706734 | ||
Targeting the heat shock factor 1 by RNA interference: a potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer. | Q51792544 | ||
Carcinogenicity of human papillomaviruses | Q58296516 | ||
Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study | Q24810933 | ||
The global health burden of infection-associated cancers in the year 2002 | Q28290871 | ||
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells | Q28366303 | ||
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen | Q29616224 | ||
Anticancer activities of histone deacetylase inhibitors | Q29616624 | ||
Angiogenesis inhibitors: perspectives for medical, surgical and radiation oncology | Q33250215 | ||
Valproate and valproate-analogues: potent tools to fight against cancer. | Q34144072 | ||
Anti-tumor mechanisms of valproate: a novel role for an old drug | Q34147644 | ||
Valproic acid modulates NCAM polysialylation and polysialyltransferase mRNA expression in human tumor cells. | Q34394231 | ||
Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies. | Q36002354 | ||
Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets | Q36262349 | ||
Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment | Q36369889 | ||
Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch | Q36576720 | ||
Molecular biology of cervical cancer | Q36862117 | ||
The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth | Q38299684 | ||
Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model | Q40128564 | ||
Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy | Q40228873 | ||
Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts | Q40245242 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cervix uterine cancer | Q160105 |
P304 | page(s) | 357-362 | |
P577 | publication date | 2008-05-31 | |
P1433 | published in | Journal of Biochemistry | Q6294839 |
P1476 | title | Valproic acid inhibits the growth of cervical cancer both in vitro and in vivo | |
P478 | volume | 144 |
Q34113695 | Chromatin remodeling, cell proliferation and cell death in valproic acid-treated HeLa cells |
Q36257542 | DNA Methylation Changes in Valproic Acid-Treated HeLa Cells as Assessed by Image Analysis, Immunofluorescence and Vibrational Microspectroscopy |
Q34366588 | Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell line |
Q44014855 | Epilepsy, anti-epileptic medication use and risk of cancer |
Q42703577 | Inhibitory effect of snake venom toxin on NF-κB activity prevents human cervical cancer cell growth via increase of death receptor 3 and 5 expression |
Q97419293 | Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression |
Q39435592 | Reduced glutamine concentration improves protein production in growth-arrested CHO-DG44 and HEK-293E cells |
Q36524716 | Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges |
Q37110658 | Transcriptional regulation of E-cadherin and oncoprotein E7 by valproic acid in HPV positive cell lines |
Q38849324 | Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide-drug conjugate via activating somatostatin receptor type II. |
Q36335796 | Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation |
Q38788965 | Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1α/VEGF signals |
Q39013397 | Valproic acid inhibits the proliferation of SHSY5Y neuroblastoma cancer cells by downregulating URG4/URGCP and CCND1 gene expression |
Q45912062 | Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II. |
Q51742940 | miR-2861 as novel HDAC5 inhibitor in CHO cells enhances productivity while maintaining product quality. |